Eli Lilly Outsourcing Clinical Trial Support to Thermo Fisher in Massachusetts
Posted Mar 28 2010 10:56pm
Instead of being done in house, Thermo Fisher will be the outsourced agent here for materials, packaging and labeling products used in trials. Lilly employees can apply for jobs at Thermo Fisher as they are released from the company. Clinical trials are not getting any cheaper to put on and with outsourcing for a lesser expense, Lilly like many other pharma companies looks to cut costs.
This is starting to sound like a pharmacy benefit manager type of operation, a clinical trial benefit group. In addition the face of clinical trials is changing with technology as well with data being collected via devices that report data too. You may be wearing a shirt like this one in the future if you participate in a trial so they can have all your vitals and information at all times too.
To assist healthcare providers with using this data to proactively intervene in a patient’s care, VivoMetrics® has partnered with another industry leader, OBS Medical, to incorporate their technology-award winning Visensia software as a predictive tool to improve patient care and safety and optimize clinical resources.
VivoMetrics® is a contributing member of the Continua Health Alliance, a coalition of telehealth providers committed to creating an interoperable system of personal telehealth solutions that aim to foster independence and empower people to better manage their health and wellness.
In clinical trials you tend to have a pretty captive audience with many treatments looking to be cures or long time treatments so the expense of gathering and analyzing all the information is becoming a challenge as well. Read below for a few other devices that are emerging into the market place and perhaps some you may see soon as part of a trial solution for data. BD
Thermo Fisher Scientific Inc. (NYSE:TMO) inked a five-year supply deal with Eli Lilly & Co. (NYSE:LLY) that will see it take over some of the pharma giant's clinical trial operations in Indianapolis.
Waltham, Mass.-based Thermo Fisher said its Fisher Clinical Services subsidiary will take over Lilly's in-house clinical trial materials manufacturing, packaging and labeling operations in the Circle City. That transition should be done some time this summer, and by the end of the year TMO will have taken over the clinical trial materials distribution throughout North America.